Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of candesartan + hydrochlorothiazide in Chinese patients with primary hypertension
ChiCTR2000041306Phase 2Completed
- Sponsor
- Fuwai Hospital
- Start
- Jul 2005
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of candesartan and hydrochlorothiazide in essential hypertension (3 arms), sponsored by Fuwai Hospital. Primary endpoint: SeDBP. Started Jul 2005; status: completed.
02
Drugs
candesartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2000041306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041306.